Compare TRT & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRT | ECOR |
|---|---|---|
| Founded | 1958 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.1M | 100.3M |
| IPO Year | 1995 | 2018 |
| Metric | TRT | ECOR |
|---|---|---|
| Price | $5.13 | $7.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $19.17 |
| AVG Volume (30 Days) | ★ 397.8K | 71.7K |
| Earning Date | 09-24-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.00 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $32,462,000.00 | $32,032,000.00 |
| Revenue This Year | $26.89 | $30.85 |
| Revenue Next Year | $25.30 | $29.71 |
| P/E Ratio | $365.50 | ★ N/A |
| Revenue Growth | N/A | ★ 27.20 |
| 52 Week Low | $1.63 | $4.41 |
| 52 Week High | $21.38 | $12.70 |
| Indicator | TRT | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 29.35 | 24.35 |
| Support Level | $4.83 | $5.59 |
| Resistance Level | $5.59 | $7.24 |
| Average True Range (ATR) | 0.32 | 0.69 |
| MACD | 0.11 | -0.25 |
| Stochastic Oscillator | 20.65 | 4.93 |
Trio-Tech International is a provider of reliability test equipment and services to the semiconductor and other industries. Its customers are from automotive electronics, industrial electronics, computing and data storage, consumer electronics, and communication markets. The company operated its business in two segments: Semiconductor Back-end Solutions and Industrial Electronics. Geographically, the company operates in the United States (U.S), Singapore, Malaysia, Thailand and China.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.